Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120830215 | 12083021 | 5 | F | 20160725 | 20160217 | 20160801 | PER | US-PFIZER INC-2016078048 | PFIZER | 58.00 | YR | F | Y | 0.00000 | 20160801 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120830215 | 12083021 | 1 | PS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | U | 20699 | TABLET | |||||||||
| 120830215 | 12083021 | 2 | SS | PROMETHAZINE HCL | PROMETHAZINE HYDROCHLORIDE | 1 | UNK | U | 0 | SOLUTION FOR INJECTION | |||||||||
| 120830215 | 12083021 | 3 | SS | CORTISONE | CORTISONEHYDROCORTISONE | 1 | UNK | U | 8126 | TABLET | |||||||||
| 120830215 | 12083021 | 4 | SS | ENBREL | ETANERCEPT | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | UNK | U | 11719 | ||||||||||
| 120830215 | 12083021 | 6 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 7 | SS | CODEINE | CODEINE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 9 | SS | LEUCOVORIN CALCIUM. | LEUCOVORIN CALCIUM | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 10 | SS | BIAXIN | CLARITHROMYCIN | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 11 | SS | ACIPHEX | RABEPRAZOLE SODIUM | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 12 | SS | CARAFATE | SUCRALFATE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 13 | SS | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 14 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 15 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 16 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 17 | SS | HCTZ | HYDROCHLOROTHIAZIDE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 18 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 19 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 20 | SS | MOBIC | MELOXICAM | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 21 | SS | BUSPAR | BUSPIRONE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 22 | SS | ORENCIA | ABATACEPT | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 23 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 24 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 25 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 26 | SS | KEFLEX | CEPHALEXIN | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 27 | SS | AMITIZA | LUBIPROSTONE | 1 | UNK | U | 0 | ||||||||||
| 120830215 | 12083021 | 28 | SS | ALIGN | BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120830215 | 12083021 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |